Changes in the expression of stimulatory and inhibitory immune checkpoints of peripheral blood lymphocytes in patients with advanced lung cancer before and after anti-PD-1 antibody treatment and their relationship with the progression of the disease

Wu-shuang DU,Yi HU,Shun-chang JIAO,Yan-zhe LIU
2018-01-01
Abstract:Objective To investigate the relationship between the change of immune check point before and after anti-PD-1 monoclonal antibody treatment and the curative effect.Methods Peripheral blood samples of 16 patients who were treated with anti-PD-1 mAb for lung cancer were collected before each treatment.The expressions of PD-1,CTLA-4,TIM-3,LAG-3,BTLA,CD160,Ki-67,OX40 and GITR in T lymphocytes were detected by flow cytometry.Results The patients were divided into two groups according to the results of two-period evaluation.The expressions of PD-1,CTLA-4 and Ki-67 in the two groups were statistically significant(P <0.05),and there was no statistical significance in the difference between the two groups (P > 0.05).The expressions of PD-1,CTLA-4,LAG-3,BTLA,CD160 and Ki-67 increased in different degree after immunotherapy,which was statistically significant.Conclusion Multiple immune checkpoint expression is correlated with efficacy,which can be used as an early prediction of immunotherapy efficacy in patients with indicators.
What problem does this paper attempt to address?